In a study comparing the effects of two treatments, the propensity score is the probability of assignment to one treatment conditional on a subject's measured baseline covariates. Propensity-score matching is increasingly being used to estimate the effects of exposures using observational data. In the most common implementation of propensity-score matching, pairs of treated and untreated…
Pharmaceutical Statistics Template
Write in a clean editor, then format for Pharmaceutical Statistics in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Pharmaceutical Statistics format
Pharmaceutical Statistics is a peer-reviewed journal published by Wiley, covering Statistical Methods in Clinical Trials, Optimal Experimental Design Methods, Advanced Causal Inference Techniques.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Pharmaceutical Statistics 12 (3): 45–58.
Formats any DOI in Pharmaceutical Statistics style. No sign-up. |
| Publishes research in | Statistical Methods in Clinical Trials Optimal Experimental Design Methods Advanced Causal Inference Techniques Health Systems, Economic Evaluations, Quality of Life Statistical Methods and Bayesian Inference |
| ISSN | 1539-1604 |
| Citation impact (2-yr) | 1.52 |
| h-index | 60 |
| i10-index | 479 |
| Total citations | 29,418 |
| Article processing charge | $4,430 |
| Top institutions publishing here | Novartis (Switzerland) |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Pharmaceutical Statistics per year
Citation impact of Pharmaceutical Statistics by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Pharmaceutical Statistics
Abstract When designing a clinical trial an appropriate justification for the sample size should be provided in the protocol. However, there are a number of settings when undertaking a pilot trial when there is no prior information to base a sample size on. For such pilot studies the recommendation is a sample size of 12…
This article provides minimum requirements for having confidence in the accuracy of EC50/IC50 estimates. Two definitions of EC50/IC50s are considered: relative and absolute. The relative EC50/IC50 is the parameter c in the 4-parameter logistic model and is the concentration corresponding to a response midway between the estimates of the lower and upper plateaus. The absolute…
Clinical trials rarely, if ever, occur in a vacuum. Generally, large amounts of clinical data are available prior to the start of a study, particularly on the current study's control arm. There is obvious appeal in using (i.e., 'borrowing') this information. With historical data providing information on the control arm, more trial resources can be…
Dichotomization is the transformation of a continuous outcome (response) to a binary outcome. This approach, while somewhat common, is harmful from the viewpoint of statistical estimation and hypothesis testing. We show that this leads to loss of information, which can be large. For normally distributed data, this loss in terms of Fisher's information is at…